$9.72
1.67% day before yesterday
Nasdaq, Nov 28, 09:54 pm CET
ISIN
US76200L3096
Symbol
RZLT

Rezolute Inc Stock price

$9.72
+0.23 2.42% 1M
+5.77 146.08% 6M
+4.82 98.37% YTD
+4.73 94.79% 1Y
+8.12 507.50% 3Y
-10.28 51.40% 5Y
-67.78 87.46% 10Y
-21.78 69.14% 20Y
Nasdaq, Closing price Fri, Nov 28 2025
+0.16 1.67%
ISIN
US76200L3096
Symbol
RZLT
Industry

Key metrics

Basic
Market capitalization
$901.3m
Enterprise Value
$749.1m
Net debt
positive
Cash
$152.2m
Shares outstanding
91.0m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
- | -
EV/Sales
- | -
EV/FCF
negative
P/B
6.1
Financial Health
Equity Ratio
92.4%
Return on Equity
-45.9%
ROCE
-55.7%
ROIC
-
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$0.0 | $0.0
EBITDA
$-82.7m | -
EBIT
$-82.7m | $-111.5m
Net Income
$-77.5m | $-103.3m
Free Cash Flow
$-70.5m
Growth (TTM | estimate)
Revenue
- | -
EBITDA
-16.2% | -
EBIT
-16.1% | -39.5%
Net Income
-12.4% | -38.8%
Free Cash Flow
-13.0%
Margin (TTM | estimate)
Gross
-
EBITDA
- | -
EBIT
-
Net
- | -
Free Cash Flow
-
More
EPS
$-0.7
FCF per Share
$-0.8
Short interest
17.8%
Employees
68
Rev per Employee
$0.0
Show more

Is Rezolute Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,070 stocks worldwide.

Rezolute Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

16 Analysts have issued a Rezolute Inc forecast:

15x Buy
94%
1x Hold
6%

Analyst Opinions

16 Analysts have issued a Rezolute Inc forecast:

Buy
94%
Hold
6%

Financial data from Rezolute Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
- -
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 21 21
37% 37%
-
- Research and Development Expense 62 62
10% 10%
-
-83 -83
16% 16%
-
- Depreciation and Amortization 0.03 0.03
25% 25%
-
EBIT (Operating Income) EBIT -83 -83
16% 16%
-
Net Profit -77 -77
12% 12%
-

In millions USD.

Don't miss a Thing! We will send you all news about Rezolute Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Rezolute Inc Stock News

Neutral
Seeking Alpha
18 days ago
Rezolute, Inc. ( RZLT ) Discusses Clinical Progress and Market Opportunity for Ersodetug in Hyperinsulinism November 10, 2025 12:00 PM EST Company Participants Christen Baglaneas Nevan Elam - Founder, CEO, Principal Financial Officer & Acting Chairman of the Board Brian Roberts - Chief Medical Officer Sunil Karnawat Sunil Karnawat - Chief Commercial Officer Conference Call Participants Mansa Kr...
Neutral
GlobeNewsWire
18 days ago
REDWOOD CITY, Calif., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (NASDAQ: RZLT), (“Rezolute” or the “Company”), a late-stage rare disease company focused on treating hypoglycemia caused by hyperinsulinism, today announced that it has granted as of October 31, 2025 equity inducement awards to two new employees. The equity awards were approved by the Compensation Committee of the Company's ...
Neutral
GlobeNewsWire
22 days ago
REDWOOD CITY, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage rare disease company focused on treating hypoglycemia caused by hyperinsulinism, today reported financial results and provided a business update for the three months ended September 30, 2025.
More Rezolute Inc News

Company Profile

Rezolute, Inc. is biopharmaceutical company, which engages in the development of drug therapies for patients with metabolic and orphan diseases. Its products portfolio include RZ358-Phase 2, an antibody for the ultra-orphan indication of congenital hyperInsulinism; AB101-Phase 1, a once-weekly injectable basal insulin; and RZ402 which targets diabetic macular edema. The company was founded by Nevan Charles Elam, Ho Young Huh, and Sankaram Mantripragada on July 26, 2010 and is headquartered in Redwood City, CA.

Head office United States
CEO Nevan Elam
Employees 68
Founded 2010
Website www.rezolutebio.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today